ISTA Pharmaceuticals Reports Third Quarter 2006 Financial Results and Expresses Comfort with Analyst Revenue (FinanzNachrichten)
IRVINE, Calif., Nov. 2 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, ( Nachrichten ) Inc. , an ophthalmic pharmaceutical company, today reported net revenues of $8.7 million for the three months ended September 30, 2006, as compared to $3.6 million for the same period in 2005. Net product sales for the third quarter of 2006 included Xibrom(TM) net sales of $5.6 million, Istalol(R) net sales of

FDA Incident Reporting System Available Online at PDMAAlliance.org (Business Wire via Yahoo! Finance)
CRANBURY, N.J.----The PDMA Alliance, a cooperative organization of pharmaceutical manufacturers and their business partners dedicated to improving the understanding of and compliance with the Prescription Drug Marketing Act of 1987 , has announced that it has successfully launched an online system for reporting loss, theft and other incidents involving drug samples to the U.S.